Graham Capital Management, L.P. Harmony Biosciences Holdings, Inc. Transaction History
Graham Capital Management, L.P.
- $4.38 Billion
- Q1 2025
A detailed history of Graham Capital Management, L.P. transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Graham Capital Management, L.P. holds 16,315 shares of HRMY stock, worth $577,877. This represents 0.01% of its overall portfolio holdings.
Number of Shares
16,315
Previous 14,690
11.06%
Holding current value
$577,877
Previous $505,000
7.13%
% of portfolio
0.01%
Previous 0.01%
Shares
10 transactions
Others Institutions Holding HRMY
# of Institutions
278Shares Held
44.8MCall Options Held
130KPut Options Held
46.5K-
Valor Management LLC Chicago, IL6.62MShares$234 Million91.68% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$207 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.7MShares$166 Million0.0% of portfolio
-
State Street Corp Boston, MA1.58MShares$55.9 Million0.0% of portfolio
-
American Century Companies Inc Kansas City, MO1.29MShares$45.6 Million0.03% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $2.1B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...